Twist Bioscience (TWST) EBIT Margin (2017 - 2026)
Twist Bioscience (TWST) posted quarterly EBIT Margin of 41.42% for Q1 2026, up 336.0% YoY from 9.5% in Q1 2025, and down 30.57% sequentially from 31.73% in Q4 2025.
Twist Bioscience (TWST) EBIT Margin (2017 - 2026) Analysis & Trends
Twist Bioscience has disclosed EBIT Margin across 10 years of filings, most recently posting 41.42% for Q1 2026.
- In Q1 2026, EBIT Margin rose 336.0% year-over-year to 41.42%; the TTM figure through Mar 2026 stood at 33.9% (up 2396.0% YoY), while the FY2025 annual figure was 36.18%, up 3437.0% from the prior year.
- EBIT Margin slipped to 41.42% in Q1 2026, from 31.73% in the prior quarter.
- Over the last five years, EBIT Margin for TWST reached as high as 30.23% in Q3 2025 and fell as low as 126.34% in Q1 2022.
- The 5-year median for EBIT Margin is 65.7% (2023), against an average of 70.02%.
- Annual changes were most pronounced in 2024 — EBIT Margin plunged 1380 bps — and 2025, when it soared 7780 bps.
- A 5-year view of EBIT Margin shows it stood at 82.28% in 2022, then climbed by 20 bps to 65.7% in 2023, then surged by 41 bps to 39.05% in 2024, then rose by 19 bps to 31.73% in 2025, then plunged by 31 bps to 41.42% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 41.42%, 31.73%, and 30.23% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 31.78% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -13.42% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 21.74% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 25.23% |
| 10 | Twist Bioscience | 6.31 Bn | 6.14 Bn | 57.12 Mn | -41.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.42% |
| Dec 31, 2025 | -31.73% |
| Sep 30, 2025 | -30.23% |
| Jun 30, 2025 | -31.36% |
| Mar 31, 2025 | -44.79% |
| Dec 31, 2024 | -39.05% |
| Sep 30, 2024 | -42.55% |
| Jun 30, 2024 | -109.15% |
| Mar 31, 2024 | -64.92% |
| Dec 31, 2023 | -65.70% |
| Sep 30, 2023 | -74.85% |
| Jun 30, 2023 | -95.36% |
| Mar 31, 2023 | -102.42% |
| Dec 31, 2022 | -82.28% |
| Sep 30, 2022 | -99.24% |
| Jun 30, 2022 | -109.00% |
| Mar 31, 2022 | -126.34% |
| Dec 31, 2021 | -133.13% |
| Sep 30, 2021 | -104.90% |
| Jun 30, 2021 | -120.28% |